Valuation: Danaher Corporation

Capitalization 170B 144B 134B 126B 234B 15,532B 248B 1,530B 606B 7,337B 636B 623B 26,849B P/E ratio 2025 *
46.1x
P/E ratio 2026 * 35.3x
Enterprise value 183B 156B 145B 136B 253B 16,761B 268B 1,651B 654B 7,917B 686B 672B 28,972B EV / Sales 2025 *
7.46x
EV / Sales 2026 * 7.04x
Free-Float
72.69%
Yield 2025 *
0.52%
Yield 2026 * 0.57%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.81%
1 week+0.08%
Current month+4.88%
1 month+5.29%
3 months+10.08%
6 months+26.42%
Current year+4.88%
More quotes
1 week 231.1
Extreme 231.1
242.8
1 month 227.23
Extreme 227.23
242.8
Current year 227.23
Extreme 227.23
242.8
1 year 171
Extreme 171
258.23
3 years 171
Extreme 171
281.7
5 years 171
Extreme 171
333.96
10 years 75.71
Extreme 75.71
333.96
More quotes
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2020
Director of Finance/CFO 54 01/01/2019
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1983
Director/Board Member 69 01/01/1983
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.81%+0.08%-1.68%-12.51% 170B
+0.50%+2.37%+11.29%+7.71% 240B
+0.40%-2.87%-13.87%+104.78% 186B
-0.46%+1.40%-8.99%+100.11% 135B
-1.17%-5.72%-19.67%-10.92% 57.83B
-0.82%-0.06%+22.31%+6.50% 49B
-0.82%-4.28%-9.15%-11.09% 39.3B
-1.52%-2.05%+3.24%+8.78% 37.19B
+0.97%-0.75%-6.23%+22.64% 37.3B
-0.92%-5.18%-15.64%-43.26% 33.56B
Average -0.46%-1.57%-3.84%+17.27% 98.58B
Weighted average by Cap. -0.20%-0.51%-2.45%+32.24%
See all sector performances

Financials

2025 *2026 *
Net sales 24.52B 20.87B 19.38B 18.17B 33.84B 2,246B 35.88B 221B 87.7B 1,061B 91.96B 90.08B 3,883B 25.51B 21.71B 20.16B 18.9B 35.2B 2,336B 37.32B 230B 91.21B 1,104B 95.64B 93.69B 4,038B
Net income 3.7B 3.15B 2.93B 2.74B 5.11B 339B 5.42B 33.42B 13.24B 160B 13.89B 13.6B 586B 4.83B 4.11B 3.81B 3.58B 6.66B 442B 7.06B 43.54B 17.26B 209B 18.09B 17.72B 764B
Net Debt 13.41B 11.41B 10.6B 9.94B 18.51B 1,228B 19.62B 121B 47.96B 580B 50.29B 49.26B 2,123B 9.92B 8.44B 7.84B 7.35B 13.69B 908B 14.51B 89.5B 35.47B 429B 37.19B 36.43B 1,570B
More financial data * Estimated data
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (41% of net sales); - life sciences equipment (30.7%); - biotechnology equipment (28.3%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (41.6%), China (11.7%) and other (46.7%).
Employees
62,000
More about the company
Date Price Change Volume
22/01/26 240.08 $ -0.81% 2,955,118
21/01/26 242.05 $ +3.29% 5,042,946
20/01/26 234.33 $ -0.70% 4,326,413
16/01/26 235.99 $ -1.63% 3,904,435
15/01/26 239.89 $ +0.82% 2,861,810

Delayed Quote Nyse, January 23, 2026 at 01:00 am

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
240.08USD
Average target price
263.05USD
Spread / Average Target
+9.57%
Consensus

Quarterly revenue - Rate of surprise